Footnotes

• Competing interests DLB is on the advisory board for Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences. He is also on the board of directors for the Boston VA Research Institute, the Society of Cardiovascular Patient Care and is chair of the American Heart Association Get With The Guidelines Steering Committee. He has received honoraria from the American College of Cardiology (Editor, Clinical Trials, Cardiosource), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today's Intervention), and WebMD (CME steering committees). Additionally, he is on Data Monitoring Committees for Duke Clinical Research Institute, Mayo Clinic and the Population Health Research Institute. He has received research grants from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi, and The Medicines Company and also has done unfunded research with FlowCo, PLx Pharma, and Takeda. Lastly, he is on the Executive Committee of ODYSSEY (a cardiovascular outcome study of a PCSK9 inhibitor made by Sanofi).